Finance

Beta
Lists
ACIU:NASDAQ
AC Immune SA
$2.12
-5.97%
(-0.13) 1D
Jun 10, 11:40:47 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ACIU...
Open
$2.22
High
$2.22
Low
$2.10
Mkt. cap
215.86M
Avg. vol.
294.41K
Volume
238.91K
52-wk high
$4.00
52-wk low
$1.65
EPS
-$0.83
Beta
1.59
Shares outstanding
101.77M
No. of employees
106
Open
$2.22
High
$2.22
Low
$2.10
Mkt. cap
215.86M
Avg. vol.
294.41K
Volume
238.91K
52-wk high
$4.00
52-wk low
$1.65
EPS
-$0.83
Beta
1.59
Shares outstanding
101.77M
No. of employees
106
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to ACIU in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ACIU in the last 3 months.
Highest
Current $2.12
$12.00 (+464.71%)
Average
$10.00 (+370.59%)
Lowest
$8.00 (+276.47%)
News stories
From sources across the web
About AC Immune SA
CEOAndrea Pfeifer
Employees106
Founded2003
Headquarters-
SectorBiotechnology
Websiteacimmune.com
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.31M
939.00K
338.00K
1.12M
Cost of goods sold
16.83M
13.07M
10.62M
11.74M
Cost of revenue
16.83M
13.07M
10.62M
11.74M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.90M
3.57M
4.19M
4.17M
Operating expense
3.87M
3.57M
4.12M
4.16M
Total operating expenses
20.69M
16.64M
14.74M
15.91M
Operating income
-19.39M
-15.70M
-14.41M
-14.79M
Other non operating income
-
-
-
-
EBT including unusual items
-21.19M
-15.86M
-14.37M
-14.80M
EBT excluding unusual items
-21.19M
-15.39M
-14.38M
-14.80M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-28.00K
-
-73.00K
-11.00K
Net income
-21.19M
-15.86M
-14.37M
-14.80M
Net profit margin
-1,622.43%
-1,688.82%
-4,252.37%
-1,322.70%
Earnings per share
-0.21
-0.16
-0.14
-0.15
Interest and investment income
458.00K
366.00K
353.00K
228.00K
Interest expense
-50.00K
-46.00K
-42.00K
-65.00K
Net interest expenses
408.00K
320.00K
311.00K
163.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-19.02M
-15.36M
-14.08M
-14.44M
Gain or loss from assets sale
-15.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer